Fulgent Genetics (FLGT) Short-term Investments (2016 - 2026)
Fulgent Genetics' Short-term Investments history spans 11 years, with the latest figure at $252.9 million for Q1 2026.
- On a quarterly basis, Short-term Investments changed 0.05% to $252.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $252.9 million, a 0.05% change, with the full-year FY2025 number at $285.9 million, up 40.86% from a year prior.
- Short-term Investments hit $252.9 million in Q1 2026 for Fulgent Genetics, down from $285.9 million in the prior quarter.
- Over the last five years, Short-term Investments for FLGT hit a ceiling of $446.7 million in Q4 2022 and a floor of $155.0 million in Q3 2024.
- Historically, Short-term Investments has averaged $301.0 million across 5 years, with a median of $258.2 million in 2025.
- Biggest five-year swings in Short-term Investments: soared 88.89% in 2023 and later tumbled 59.6% in 2024.
- Tracing FLGT's Short-term Investments over 5 years: stood at $446.7 million in 2022, then fell by 26.87% to $326.7 million in 2023, then plummeted by 37.87% to $203.0 million in 2024, then surged by 40.86% to $285.9 million in 2025, then fell by 11.54% to $252.9 million in 2026.
- Business Quant data shows Short-term Investments for FLGT at $252.9 million in Q1 2026, $285.9 million in Q4 2025, and $258.2 million in Q3 2025.